tiprankstipranks
Trending News
More News >

Linical Revises Fiscal Forecast Amid Global Challenges, Records Tax Gain

Story Highlights
Linical Revises Fiscal Forecast Amid Global Challenges, Records Tax Gain

Don’t Miss TipRanks’ Half-Year Sale

Linical Co., Ltd. ( (JP:2183) ) just unveiled an update.

Linical Co., Ltd. has revised its consolidated financial forecast for the fiscal year ending March 2025 due to underperformance in new project acquisitions and project delays across Japan, South Korea, Europe, and the United States. Despite the forecasted downturn, Linical has recorded a gain of 107 million yen from income tax adjustments and maintains its dividend forecast, highlighting its commitment to balancing corporate growth and shareholder returns.

More about Linical Co., Ltd.

Linical Co., Ltd. operates within the pharmaceutical and clinical research industry, focusing on providing clinical development solutions. The company serves a global market, including regions such as Japan, South Korea, Europe, and the United States.

Average Trading Volume: 48,225

Technical Sentiment Consensus Rating: Buy

Current Market Cap: Yen7.86B

See more data about 2183 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1